Peer-reviewed report on Moderna COVID-19 vaccine publishes

IMAGE: Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, receives the Moderna COVID-19 vaccine at the HHS/NIH COVID-19 Vaccine Kick-Off event at NIH on 12/22/20…. view more  Credit: NIH WHAT: The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from […]

Published data from Moderna COVID-19 vaccine trial show 94.1 percent efficacy

BOSTON — A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc. Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine can prevent symptomatic infection. […]

How the FDA-authorized Moderna COVID-19 vaccine compares to Pfizer’s

A second coronavirus vaccine has now joined the fight against COVID-19 in the United States. On December 18, the U.S. Food and Drug Administration authorized Moderna’s vaccine for emergency use in people 18 years or older. The decision follows a thumbs-up vote from a panel of experts that convened on December 17 to discuss vaccine […]

Moderna coronavirus vaccine is 94.5% effective, early results suggest

Moderna’s experimental coronavirus vaccine is 94.5% effective in protecting against infection with the coronavirus, according to early data released by the Cambridge, Massachusetts-based company Monday (Nov. 16).  This comes a week after Pfizer’s announcement that its vaccine is more than 90% effective, Live Science previously reported.Though the clinical trials from both companies are still in […]

Moderna says its COVID-19 vaccine is nearly 95 percent effective

On the heels of the preliminary success of one COVID-19 vaccine in the United States, another leading vaccine candidate is showing promise. Preliminary results indicate that Moderna’s coronavirus vaccine is nearly 95 percent effective in preventing sickness, including severe cases of the disease, the biotechnology company announced November 16.  “This is a pivotal moment in […]